Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer
C J A Punt, C D Blanke, J Zhang, et al.
Current Oncology (Toronto, Ont.)
|
December 7, 2013
Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer
H Kennecke, L Chen, C D Blanke, et al.
The Annals of Thoracic Surgery
|
February 10, 1998
Prognosis of adenocarcinoma arising in Barrett's esophagus
S J Hoff, J L Sawyers, C D Blanke, et al.
Investigational New Drugs
|
October 10, 2008
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer
C D Blanke, T M Beer, K Todd, et al.
Annals of Surgical Oncology
|
November 24, 1999
Nonoperative management of primary colorectal cancer in patients with stage IV disease
C R Scoggins, I M Meszoely, C D Blanke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices
P W T Pisters, C D Blanke, M von Mehren, et al.
Seminars in Radiation Oncology
|
April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer
C D Blanke, H Choy, M Teng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2011
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer
S Iqbal, B Goldman, C M Fenoglio-Preiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
C D Blanke, D G Haller, A B Benson, et al.
Cancer
|
April 13, 2000
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II study
W John, J Picus, C D Blanke, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer
C J A Punt, C D Blanke, J Zhang, et al.
Current Oncology (Toronto, Ont.)
|
December 7, 2013
Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer
H Kennecke, L Chen, C D Blanke, et al.
The Annals of Thoracic Surgery
|
February 10, 1998
Prognosis of adenocarcinoma arising in Barrett's esophagus
S J Hoff, J L Sawyers, C D Blanke, et al.
Investigational New Drugs
|
October 10, 2008
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer
C D Blanke, T M Beer, K Todd, et al.
Annals of Surgical Oncology
|
November 24, 1999
Nonoperative management of primary colorectal cancer in patients with stage IV disease
C R Scoggins, I M Meszoely, C D Blanke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices
P W T Pisters, C D Blanke, M von Mehren, et al.
Seminars in Radiation Oncology
|
April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer
C D Blanke, H Choy, M Teng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2011
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer
S Iqbal, B Goldman, C M Fenoglio-Preiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
C D Blanke, D G Haller, A B Benson, et al.
Cancer
|
April 13, 2000
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II study
W John, J Picus, C D Blanke, et al.
Page
of 3